Powering a trial for superiority can be financially risky. In some instances it may also prove unnecessary.
Why You Should Not Power for Superiority Upfront: Promising Zone Clinical Trials with "Adaptive Switch"
Posted by Esha Senchaudhuri
Jun 26, 2015 12:00:06 PM
Topics: Cyrus Mehta, Promising Zone, Cardiovascular, Adaptive Clinical Trials, Adaptive Finance
New Articles on Adaptive Clinical Trials & Adaptive Financing
Posted by Esha Senchaudhuri
Apr 30, 2015 5:00:00 PM
Adaptive financing (not to be confused with adaptive licensing) explores how biotechs, pharmaceuticals and potential investors, can use adaptive designs for more strategic financial decision-making, as well as for efficient drug development.
“For example,” writes Zoran Antonijevic, Senior Director at Cytel Consulting, “Reduction in costs and development time can be accomplished by combining...
Topics: Clinical Development Strategy, Adaptive Clinical Trials, Adaptive Finance
The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics. Sign up for updates direct to your inbox. You can unsubscribe at any time.
Posts by Topic
- biostatistics (96)
- Adaptive Clinical Trials (82)
- Statistical Programming (56)
- Clinical Research Services (51)
- Clinical Development Strategy (47)
- adaptive designs (46)
- Oncology (40)
- Clinical Data (38)
- adaptive trials (35)
- Statistical Analysis (32)
- Data Management (31)
- Bayesian Methods (30)
- clinical trials (27)
- Cytel Strategic Consulting (25)
- Trial Design (23)
- CDISC (22)
- clinical research (21)
- Cytel Consulting (20)
- Early Phase Trials (20)
- Phase 3 (20)
- East (19)
- Interim Analyses (19)
- pharmacometrics (19)
- Phase 1 (18)
- phase 2 (18)
- Regulation (17)
- data manager (17)
- SDTM (16)
- careers (16)
- clinical development (16)
- data science (16)
- EAST 6.4 (15)
- EDC (15)
- SAS (15)
- patient enrollment (15)
- Cyrus Mehta (14)
- Dose-Escalation (14)
- Simulations (13)
- CRO (12)
- Dose-Finding (12)
- FDA (12)
- Program and Portfolio Optimization (12)
- Promising Zone (12)
- Statistical Innovations in Clinical Development (12)
- database build (12)
- pharmacology (12)
- Cardiovascular (11)
- adaptive sample size re-estimation (11)
- Biometrics (10)
- Entrepreneurship (10)
- Recruitment (10)
- ADaM (9)
- Precision Medicine (9)
- big data (9)
- clinical data management (9)
- outsourcing (9)
- Access to Slides PDF (8)
- Bayesian (8)
- CDM (8)
- East 6.3 (8)
- R programming (8)
- Trial Quality (8)
- go-no-go (8)
- sample size re-estimation (8)
- Case Study (7)
- Multi-Arm Multi-Stage Studies (7)
- Multi-Arm Studies (7)
- Phase I (7)
- Software Simulations (7)
- enforesys (7)
- model-informed-drug-development (7)
- quantitative decision-making (7)
- BLRM (6)
- DMC (6)
- East ESCALATE (6)
- East PREDICT (6)
- Enrichment (6)
- Nitin Patel (6)
- R language (6)
- Training and Education (6)
- feasibility studies (6)
- Biomarkers (5)
- Cytel Videos (5)
- MCP-Mod (5)
- Marvin Zelen (5)
- R (5)
- Sample Size (5)
- real world evidence (5)
- ACES (4)
- Access to Paper PDF (4)
- CDASH (4)
- CRM (4)
- Exact Tests (4)
- Prediction (4)
- Predictive Enrichment (4)
- Rare Disease (4)
- Rstats (4)
- Safety (4)
- Seamless designs (4)
- Small Sample Sparse Data (4)
- StatXact (4)
- Trial Design Software (4)
- Trial Monitoring (4)
- forecasting (4)
- randomization (4)
- Cytel Events (3)
- Dose Selection (3)
- Group Sequential (3)
- JSM (3)
- PK/PD (3)
- PSI Conference (3)
- PhUSE (3)
- Proof-of-Concept (3)
- R&D (3)
- Simulation & Biomarkers (3)
- Statistical Puzzles (3)
- White Paper (3)
- basket trials (3)
- custom software (3)
- exact statistics (3)
- genetic algorithm (3)
- machine learning (3)
- meta-analysis (3)
- optimization (3)
- p value (3)
- type 1 error (3)
- Adaptive Finance (2)
- Blind and Unblind Trials (2)
- Compass (2)
- Computing (2)
- EMA (2)
- Education (2)
- Efficacy (2)
- Lingyun Liu (2)
- Medical Devices (2)
- Monte Carlo (2)
- Movers & Shapers (2)
- NONMEM (2)
- PMDA (2)
- Pediatric (2)
- biomedical signals (2)
- estimands (2)
- patientricity (2)
- personalized medicine (2)
- pharmacovigilance (2)
- psychiatry and neuroscience (2)
- signal detection (2)
- trial planning (2)
- Adaptive Licensing (1)
- Antibiotic resistance (1)
- Biosimilars (1)
- Composite Endpoints (1)
- Cytel CliPLab (1)
- Cytel Congratulates (1)
- East Recruit (1)
- Eearly Development (1)
- Evidence Based Medicine (1)
- Exact Inference (1)
- Exact tests for categorical data (1)
- FMCG (1)
- Fourier (1)
- HTA (1)
- ISE (1)
- ISS (1)
- Infectious Diseases (1)
- NICE (1)
- PIPE (1)
- PSI (1)
- Predicted Interval Plots (1)
- RFP (1)
- Richard Branson (1)
- Risk Based Monitoring (1)
- Sam Hsaio (1)
- Scope conference (1)
- Statistics Article full PDF (1)
- Translational Medicine (1)
- Translational Statistics (1)
- Webinar Slides (1)
- What are... (1)
- benefit risk assessment (1)
- feature selection (1)
- health economics (1)
- immunotherapy (1)
- infographic (1)
- medical ethics (1)
- medical writing (1)
- non parametric analysis (1)
- pattern recognition (1)
- permutations (1)
- population enrichment (1)
- signal processing (1)
- statistical communication (1)
- subgroup analysis (1)
- t-tests (1)
- time to event trials (1)
- time-to-even trials (1)
- treatment switch (1)
- webinar (1)